Skip to main content
SPLM logo

Sentry Petroleum Ltd (SPLM) Stock Price & Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.0001 $0.00 (0.00%)
Vol: 2.0K|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Sentry Petroleum Ltd (SPLM) trades at $0.0001. Sentry Petroleum Ltd. is an exploration stage company focused on acquiring and developing oil and gas properties. The company holds interests in exploration permits within the Adavale Basin, Queensland. Sector: Healthcare.

Price as of · Last analyzed: Mar 16, 2026
Sentry Petroleum Ltd. is an exploration stage company focused on acquiring and developing oil and gas properties. The company holds interests in exploration permits within the Adavale Basin, Queensland.

Analyst Coverage for SPLM: SPLM does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

▶ Watch the SPLM film Every key number, told as a short cinematic story — just press play. ~2 min

No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.

Sentry Petroleum Ltd (SPLM) Healthcare & Pipeline Overview

CEOSage Ellie
Employees1
HeadquartersDenver, US
IPO Year2007

Sentry Petroleum Ltd., operating in the healthcare sector as an exploration stage company, focuses on acquiring and developing oil and gas properties. With a portfolio of exploration permits in the Adavale Basin, Queensland, the company navigates the high-risk, high-reward landscape of resource exploration, while currently demonstrating minimal financial activity.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 16, 2026

What Is the Investment Thesis for SPLM?

AI-written as of Mar 16, 2026 — figures and tone reflect the data available then, not today's score.

Sentry Petroleum Ltd. presents a high-risk, high-reward investment profile characteristic of exploration stage companies. The company's value is primarily tied to the potential of its 6.9 million net acres in the Adavale Basin, Queensland. Key value drivers include successful exploration results leading to proven reserves and subsequent resource development. However, the company's financial viability hinges on securing additional funding, given its current lack of revenue and negative P/E ratio of -0.09. The high beta of 20.58 indicates extreme volatility, reflecting the speculative nature of the investment. Investors should carefully consider the risks associated with resource exploration and the company's ability to execute its development plans.

Based on FMP financials and quantitative analysis

SPLM Key Highlights

AI-written as of Mar 16, 2026 — figures and tone reflect the data available then, not today's score.

Sentry Petroleum Ltd. operates as an exploration stage company, focusing on acquiring and developing oil and gas properties.

  • The company holds 100% interests in 4 exploration permits covering approximately 6.9 million net acres in the Adavale Basin, Queensland.
  • Sentry Petroleum Ltd. has a market capitalization of $0.00B, reflecting its early stage and speculative nature.
  • The company's P/E ratio is -0.09, indicating it is not currently profitable.
  • Sentry Petroleum Ltd. has a high beta of 20.58, suggesting significant volatility compared to the overall market.

Who Are SPLM's Competitors?

SPLM is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
AKAN Akanda Corp. $1.98 -10.41% —
SNOA Sonoma Pharmaceuticals, Inc. $1.24 -0.80% $5.94M —
BFRI Biofrontera Inc. $1.01 -2.40% $13.0M —
COSM COSM $0.38 -1.58% $20.7M —
QNTM Quantum BioPharma Ltd. $3.44 +0.44% $22.0M —
AYTU Aytu BioPharma, Inc. $2.07 -0.96% $22.2M —
TXMD TherapeuticsMD, Inc. $2.05 +0.99% $23.7M —
CPHI CPHI $0.66 +0.61% $26.6M —

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are SPLM's Key Strengths?

100% ownership of 6.9 million net acres in the Adavale Basin.

  • Experienced management team in oil and gas exploration.
  • Potential for significant resource discoveries.

What Are SPLM's Weaknesses?

Exploration stage company with no current revenue.

  • High dependence on external funding for exploration and development.
  • Limited operational scale with only one employee.

What Are the Key Risks for SPLM?

Financial-distress signal — its Altman Z-Score of -6.89 sits in the distress zone (elevated bankruptcy risk).

  • Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
  • Unsuccessful exploration results could lead to a decline in asset value.
  • Fluctuations in oil and gas prices could impact the economic viability of future production.
  • Increased regulatory scrutiny and environmental concerns could delay or halt development projects.
  • Limited financial resources and dependence on external funding.
  • High beta of 20.58 indicates extreme volatility.

What Are SPLM's Competitive Advantages?

  • Exclusive rights to explore within its permit areas.
  • Potential first-mover advantage in the Adavale Basin.
  • Proprietary geological data and expertise.

What Does SPLM Do?

Founded in 2006, Sentry Petroleum Ltd., formerly known as Summit Exploration Inc., is an exploration stage company based in Denver, Colorado. The company's primary focus is the acquisition, exploration, and development of oil and gas properties. Sentry Petroleum holds 100% interests in four exploration permits (ATP 862, 864, 865, and 866) covering approximately 6.9 million net acres in the Adavale Basin, Queensland. As an exploration stage company, Sentry Petroleum is involved in the initial phases of identifying and assessing potential oil and gas reserves. The company's success depends heavily on the outcome of its exploration activities and its ability to secure funding for further development. Sentry Petroleum operates with a lean team of one employee, managed by Sage Ellie, reflecting its current stage of development and operational scale.

What Products and Services Does SPLM Offer?

  • Acquires oil and gas properties for exploration.
  • Explores acquired properties to identify potential oil and gas reserves.
  • Develops identified oil and gas reserves for commercial production.
  • Holds 100% interests in 4 exploration permits in the Adavale Basin, Queensland.
  • Manages a portfolio of exploration assets.
  • Seeks strategic partnerships for funding and development.

How Does SPLM Make Money?

  • Acquires exploration permits.
  • Conducts geological surveys and exploration activities.
  • Seeks to discover commercially viable oil and gas reserves.
  • Potentially develops reserves for production or sells/partners on the assets.

What Industry Does SPLM Operate In?

Sentry Petroleum Ltd. operates within the Drug Manufacturers - Specialty & Generic industry, a sub-sector of the broader Healthcare sector. However, its business model more closely aligns with the oil and gas exploration industry. The company's success is tied to the cyclical nature of commodity prices and the inherent risks of resource exploration. The competitive landscape includes both large, established oil and gas companies and smaller exploration firms. Sentry Petroleum's ability to differentiate itself depends on its exploration results and its ability to attract investment in a capital-intensive industry.

Who Are SPLM's Key Customers?

  • Potential future customers would be energy companies purchasing extracted resources.
  • Potential partners in joint ventures for development.
  • Potential acquirers of the company's assets.
Model self-rating on this text: 69% (not a measure of the evidence) Updated: Mar 16, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● No usable price
  • ● No filing on record
  • ● No analyst coverage

Company Profile

Sentry Petroleum Ltd operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Denver, United States.

F-Score 1/9

Financial Health

Sentry Petroleum Ltd's Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -6.89 places it in the distress zone, a signal of elevated financial risk.

SPLM Financials

SPLM Latest News

No recent news available for SPLM.

SPLM Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for SPLM.

Price Targets

Wall Street price target analysis for SPLM.

SPLM MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for SPLM; grades run from A+ (80-100) to F (below 30).

Leadership: Sage Ellie

CEO

Sage Ellie serves as the CEO of Sentry Petroleum Ltd., overseeing the company's strategic direction and operations. With a background in managing small teams, Ellie is responsible for guiding the company's exploration and development efforts in the Adavale Basin. Ellie's leadership is crucial for navigating the challenges of an exploration stage company and securing the necessary resources for future growth. Ellie manages a team of one employee.

Track Record: As CEO, Sage Ellie is responsible for guiding Sentry Petroleum through its exploration phase. Key decisions include the acquisition and management of exploration permits in the Adavale Basin. Ellie's focus is on maximizing the potential of the company's assets and attracting investment for future development. Given the company's early stage, specific milestones are tied to exploration progress and funding initiatives.

SPLM OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, encompassing stocks that may not meet the minimum financial standards or have chosen not to comply with the reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial disclosure, making it difficult for investors to assess their true value and potential. Investing in OTC Other stocks carries significant risks due to the lack of regulation and transparency compared to exchanges like the NYSE or NASDAQ.

  • OTC Tier: OTC Other
Liquidity: Liquidity for stocks on the OTC Other tier is generally very low, with wide bid-ask spreads and limited trading volume. This can make it difficult for investors to buy or sell shares without significantly impacting the price. The lack of liquidity increases the risk of price manipulation and makes it challenging to exit a position quickly. Investors should exercise extreme caution when trading SPLM due to these liquidity concerns.
OTC Risk Factors:
  • Limited financial disclosure increases the risk of investing in SPLM.
  • Low trading volume and wide bid-ask spreads can lead to price volatility.
  • Potential for price manipulation due to lack of regulatory oversight.
  • Difficulty in exiting a position quickly due to illiquidity.
  • Higher risk of fraud or mismanagement compared to listed companies.
Due Diligence Checklist:
  • Verify the company's registration and legal standing.
  • Review any available financial statements, however limited.
  • Assess the company's management team and their experience.
  • Understand the company's business model and competitive landscape.
  • Evaluate the potential risks and rewards of investing in SPLM.
  • Consult with a financial advisor before investing.
  • Monitor news and filings for any updates on the company.
Legitimacy Signals:
  • Company has been in operation since 2006.
  • Holds 100% interests in exploration permits.
  • Company has a registered office in Denver, Colorado.

Common Questions About SPLM (Healthcare)

What do analysts say about SPLM stock?

As of March 16, 2026, there is limited analyst coverage on Sentry Petroleum Ltd. due to its OTC listing and exploration stage. Key valuation metrics are difficult to assess given the company's lack of revenue and profitability.

What are the main risks for SPLM?

The main risks for Sentry Petroleum Ltd. include the uncertainty of exploration results, fluctuations in oil and gas prices, and the need for significant external funding.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

MoonshotScore is not published for this security.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Limited information available on Sentry Petroleum Ltd. due to its OTC listing and exploration stage.
  • Financial data is limited and may not be current.
  • Analysis based on available information as of March 16, 2026.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis